Corrigendum to “Design, synthesis and biological evaluation of imidazopyridazine derivatives containing isoquinoline group as potent MNK1/2 inhibitors” [Bioorg. Med. Chem. 40 (2021) 116186]
- Resource Type
- Erratum
- Source
- In
Bioorganic & Medicinal Chemistry 15 January 2022 54 - Subject
- Language
- ISSN
- 0968-0896